Home › Fabry Disease › Virginia › Arlington
Fabry Disease clinical trials in Arlington, VA
6 studies for Fabry Disease are looking for participants at sites in and around Arlington (within about 30 miles). Open a study to see who can join and how to contact the study team.
Safety, PK/PD, and Exploratory Efficacy Study of AMT-191 in Classic Fabry Disease
RecruitingPhase 1/2
- Lysosomal & Rare Disorders Research and Treatment Center, Inc, Fairfax · 11 mi away
A Study of Patients With Fabry Disease (US Specific)
RecruitingObservational study
- Lysosomal and Rare Disorders Research and Treatment Center, Inc., Fairfax · 11 mi away
A Study of Migalastat in Pediatric Subjects (2 to <12 Yrs) With Fabry Disease and Amenable GLA Variants
RecruitingPhase 3
- Lysosomal and Rare Disorders Research and Treatment Center, Inc., Fairfax · 11 mi away
A Study to Learn About the Safety and Effects of the Study Drug PRX-102 in Children and Adolescents With Fabry Disease
RecruitingPhase 2/3
- Lysosomal and Rare Disorders Research and Treatment Center Inc, Fairfax · 11 mi away
Fabry Disease Registry & Pregnancy Sub-registry
RecruitingObservational study
- O & O Alpan- Site Number : 840025, Fairfax · 11 mi away
A Multi-Country Observational Study of Safety and Effectiveness of Elfabrio® in Fabry Patients
RecruitingObservational study
- Lysosomal & Rare Disorder Research & Treatment Center (LRDRTC), Fairfax · 11 mi away
Fabry Disease trials in other cities
- Atlanta, GA6 studies
- Minneapolis, MN4 studies
- Pittsburgh, PA4 studies
- Birmingham, AL4 studies
- Cincinnati, OH4 studies
- Cedar Rapids, IA3 studies
- Chicago, IL3 studies
- Salt Lake City, UT3 studies
- New York City, NY3 studies
Other studies in Arlington
- Non-Small Cell Lung Cancer104 studies
- Metastatic Cancer53 studies
- Colorectal Cancer52 studies
- Cancer (all types)48 studies
- Ovarian Cancer46 studies
- Breast Cancer46 studies
- Lung Cancer40 studies
- Endometrial Cancer39 studies
- Pancreatic Cancer34 studies
- Head and Neck Squamous Cell Carcinoma26 studies
- Small Cell Lung Cancer23 studies
- Melanoma20 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.